United States · FDA National Drug Code directory
ROPIVACAINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-793_94b5c770-9085-490d-a39c-5c9f8c659118
- Product NDC
- 68462-793
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ROPIVACAINE HYDROCHLORIDE
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250807
- Source listing expiry
- 20271231
Source-listed ingredients
- ROPIVACAINE HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (68462-793-55) / 20 mL in 1 VIAL (68462-793-20) · 68462-793-55
- 10 VIAL in 1 CARTON (68462-793-74) / 20 mL in 1 VIAL (68462-793-20) · 68462-793-74
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →